FdaApplication
ANDA 213986
Identifiers
- fda_app_no: ANDA213986
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2024-02-06 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CITRATE | POTASSIUM CITRATE | 15MEQ | TABLET, EXTENDED RELEASE;ORAL |
| POTASSIUM CITRATE | POTASSIUM CITRATE | 10MEQ | TABLET, EXTENDED RELEASE;ORAL |
| POTASSIUM CITRATE | POTASSIUM CITRATE | 5MEQ | TABLET, EXTENDED RELEASE;ORAL |
3 products